sulfoxide has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnham, KJ; Brinck, T; Bush, AI; Haeffner, F | 1 |
| Itoh, F; Kimura, E; Kori, M; Kunitomo, J; Saitoh, M; Yamano, T | 1 |
2 other study(ies) available for sulfoxide and Alzheimer Disease
| Article | Year |
|---|---|
Generation of soluble oligomeric beta-amyloid species via copper catalyzed oxidation with implications for Alzheimer's disease: a DFT study.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Catalysis; Computer Simulation; Copper; Humans; Hydrogen Peroxide; Methionine; Models, Chemical; Models, Molecular; Molecular Structure; Oxidation-Reduction; Protein Multimerization; Safrole; Solubility | 2010 |
Enantioselective synthesis of the novel chiral sulfoxide derivative as a glycogen synthase kinase 3beta inhibitor.
Topics: Alzheimer Disease; Chemistry, Pharmaceutical; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Isomerism; Oxidation-Reduction; Safrole | 2010 |